|
KR100868587B1
(ko)
|
2002-04-03 |
2008-11-12 |
노파르티스 아게 |
Ｐｔｐａｓｅ 1ｂ 억제제로서의 5-치환된1,1-디옥소-1,2,5-티아졸리딘-3-온 유도체
|
|
GB0225986D0
(en)
|
2002-11-07 |
2002-12-11 |
Astrazeneca Ab |
Chemical compounds
|
|
UA94724C2
(en)
|
2005-12-08 |
2011-06-10 |
Новартис Аг |
Thiadiazolidinone derivatives as antidiabetic agents
|
|
CA2630448A1
(en)
|
2005-12-08 |
2007-06-14 |
Novartis Ag |
1,1,3-trioxo-1,2,5-thiadiazolidines and their use as ptp-ases inhibitors
|
|
UA94921C2
(en)
|
2005-12-08 |
2011-06-25 |
Новартис Аг |
1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
|
|
CA2647472A1
(en)
|
2006-03-31 |
2007-10-11 |
Novartis Ag |
Organic compounds
|
|
AR066820A1
(es)
|
2007-06-04 |
2009-09-16 |
Novartis Ag |
Compuestos de tiadiazolidin-3 ona
|
|
WO2009049098A2
(en)
|
2007-10-09 |
2009-04-16 |
Indiana University Research & Technology Corporation |
Materials and methods for regulating the activity of phosphatases
|
|
US9217012B2
(en)
*
|
2009-04-08 |
2015-12-22 |
Indiana University Research And Technology Corporation |
Inhibitors of protein tyrosine phosphatases
|
|
US9493436B2
(en)
|
2011-04-26 |
2016-11-15 |
Indiana University Research And Technology Corporation |
Tyrosine phosphatase inhibitors and uses thereof to modulate the activity of enzymes involved in the pathology of Mycobacterium tuberculosis
|
|
WO2015127548A1
(en)
*
|
2014-02-28 |
2015-09-03 |
The Royal Institution For The Advancement Of Learning / Mcgill University |
Tc-ptp inhibitors as apc activators for immunotherapy
|
|
EP3154555A4
(en)
*
|
2014-06-10 |
2018-02-28 |
Monash University |
Method of producing leukocytes using ptpn2 inhibition for adoptive cell transfer
|
|
MA54884A
(fr)
*
|
2015-07-01 |
2022-01-12 |
Immatics Biotechnologies Gmbh |
Neuartige peptide und kombination aus peptiden zur verwendung in der immuntherapie gegen ovarialkarzinom und andere karzinome
|
|
US20180325925A1
(en)
*
|
2015-11-06 |
2018-11-15 |
Kyungpook National University Industry-Academic Cooperation Foundation |
Composition for prevention or treatment of neuroinflammatory disease, containing protein tyrosine phosphatase inhibitor
|
|
WO2017205765A1
(en)
|
2016-05-27 |
2017-11-30 |
Yale University |
Compositions and methods for inhibiting ptpn22
|
|
WO2018227248A1
(en)
*
|
2017-06-13 |
2018-12-20 |
Monash University |
Methods and compositions for the treatment of obesity
|
|
WO2019036815A1
(en)
|
2017-08-24 |
2019-02-28 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
ENHANCEMENT OF CD8 + T LYMPHOCYTES FOR ADOPTIVE CELL THERAPY BY INHIBITING PTPN1 (PTP1B) AND PTPN2 (TC-PTP))
|
|
CN112041433A
(zh)
|
2018-03-15 |
2020-12-04 |
Ksq治疗公司 |
用于改进的免疫疗法的基因调控组合物和方法
|
|
BR112020026086A2
(pt)
|
2018-06-21 |
2021-03-23 |
Calico Life Sciences Llc |
inibidores da proteína tirosina fosfatase e métodos de uso destes
|
|
US20220081691A1
(en)
*
|
2018-08-07 |
2022-03-17 |
Dana-Farber Cancer Institute, Inc |
Modulating ptpn2 to increase immune responses and perturbing gene expression in hematopoietic stem cell lineages
|
|
IL286373B2
(en)
|
2019-03-14 |
2026-03-01 |
Calico Life Sciences Llc |
Protein tyrosine phosphate inhibitor compounds and uses thereof
|
|
CN115003315A
(zh)
|
2019-12-04 |
2022-09-02 |
莫纳什大学 |
使用ptp1b和ptpn2抑制剂激活细胞毒性白细胞的方法
|
|
EP4073242A4
(en)
|
2019-12-12 |
2024-01-03 |
Kumquat Biosciences Inc. |
Compositions and methods for potentiating immune activity
|
|
CA3162069A1
(en)
|
2019-12-18 |
2021-06-24 |
Elliot P. Farney |
Protein tyrosine phosphatase inhibitors and methods of use thereof
|
|
EP4077319A1
(en)
|
2019-12-20 |
2022-10-26 |
Calico Life Sciences LLC |
Protein tyrosine phosphatase degraders and methods of use thereof
|
|
CN113827727B
(zh)
|
2020-06-24 |
2025-04-29 |
上海交通大学医学院附属瑞金医院 |
Ptpn2抑制剂在kras突变肿瘤中的应用
|
|
MX2023002953A
(es)
|
2020-09-11 |
2023-06-01 |
Calico Life Sciences Llc |
Inhibidores de proteína tirosina fosfatasa y métodos para su uso.
|